Plasmin degradation of fibrin coatings on synthetic polymer substrates.
暂无分享,去创建一个
[1] K. Woodhouse,et al. Protein and platelet interactions with thermally denatured fibrinogen and cross-linked fibrin coated surfaces. , 1998, Biomaterials.
[2] K. Woodhouse,et al. Synthesis and characterization of degradable polyurethane elastomers containing and amino acid-based chain extender. , 1998, Journal of biomaterials science. Polymer edition.
[3] Paul Martin,et al. Wound Healing--Aiming for Perfect Skin Regeneration , 1997, Science.
[4] M. Brittberg,et al. Influence of fibrin sealant (Tisseel) on osteochondral defect repair in the rabbit knee. , 1997, Biomaterials.
[5] M. R. Jackson,et al. Tissue sealants: Current status, future potential , 1996, Nature Medicine.
[6] J. Soria,et al. The relationship between the fibrinogen D domain self-association/cross-linking site (gammaXL) and the fibrinogen Dusart abnormality (Aalpha R554C-albumin): clues to thrombophilia in the "Dusart syndrome". , 1996, The Journal of clinical investigation.
[7] Buddy D. Ratner,et al. Biomaterials Science: An Interdisciplinary Endeavor , 1996 .
[8] M. Packham,et al. Platelet Accumulation on Fibrin-coated Polyethylene: Role of Platelet Activation and Factor XIII , 1995, Thrombosis and Haemostasis.
[9] C. V. van Blitterswijk,et al. Biocompatibility of a biodegradable matrix used as a skin substitute: an in vivo evaluation. , 1994, Journal of biomedical materials research.
[10] S. Serrano,et al. Basic proteinases from Bothrops moojeni (caissaca) venom--II. Isolation of the metalloproteinase MPB. Comparison of the proteolytic activity on natural substrates by MPB, MSP 1 and MSP 2. , 1993, Toxicon : official journal of the International Society on Toxinology.
[11] J. Brash,et al. The Effect of Antithrombin III-Independent Thrombin Inhibitors and Heparin on Fibrin Accretion onto Fibrin-Coated Polyethylene , 1993, Thrombosis and Haemostasis.
[12] M. Nesheim,et al. Lys-plasminogen is a significant intermediate in the activation of Glu-plasminogen during fibrinolysis in vitro. , 1992, The Journal of biological chemistry.
[13] D. Gabriel,et al. The effect of fibrin structure on fibrinolysis. , 1992, The Journal of biological chemistry.
[14] J. Brash,et al. Interactions of thermally denatured fibrinogen on polyethylene with plasma proteins and platelets. , 1992, Journal of biomedical materials research.
[15] C. Reilly,et al. Plasminogen activator inhibitor-1 binds to fibrin and inhibits tissue-type plasminogen activator-mediated fibrin dissolution. , 1992, The Journal of biological chemistry.
[16] J. Shainoff,et al. Immunoelectrophoretic characterizations of the cross-linking of fibrinogen and fibrin by factor XIIIa and tissue transglutaminase. Identification of a rapid mode of hybrid alpha-/gamma-chain cross-linking that is promoted by the gamma-chain cross-linking. , 1991, The Journal of biological chemistry.
[17] D. Massel,et al. Clot-bound thrombin is protected from inhibition by heparin-antithrombin III but is susceptible to inactivation by antithrombin III-independent inhibitors. , 1990, The Journal of clinical investigation.
[18] M. Mayer,et al. Biochemical and biological aspects of the plasminogen activation system. , 1990, Clinical biochemistry.
[19] R. Fears. Binding of plasminogen activators to fibrin: characterization and pharmacological consequences. , 1989, The Biochemical journal.
[20] E. Lavie,et al. Structural changes in fibrin clot associated with the proteolytic activity induced by tissue type plasminogen activator. An NMR study. , 1989, Biochimica et biophysica acta.
[21] F. Castellino,et al. Plasmin-mediated fibrinolysis by variant recombinant tissue plasminogen activators. , 1989, Proceedings of the National Academy of Sciences of the United States of America.
[22] E. Haber,et al. Innovative approaches to plasminogen activator therapy. , 1989, Science.
[23] H. Redl,et al. Morphometric studies on wound healing after systemic administration of adriamycin and local application of fibrin sealant. Application of a new wound healing model using spongiosa implants. , 1986, Pathology, research and practice.
[24] B. Norrman,et al. Fibrinolysis mediated by tissue plasminogen activator. Disclosure of a kinetic transition. , 1985, European journal of biochemistry.
[25] V. Marder,et al. PLASMIN DEGRADATION OF CROSS‐LINKED FIBRIN * , 1983, Annals of the New York Academy of Sciences.
[26] M. Hoylaerts,et al. Fibrinolytic properties of one-chain and two-chain human extrinsic (tissue-type) plasminogen activator. , 1982, The Journal of biological chemistry.
[27] C. Francis,et al. Detection of circulating crosslinked fibrin derivatives by a heat extraction-SDS gradient gel electrophoretic technique. , 1979, Blood.